Health-Ecore joins €1.8M DELPHI project to advance personalized lung cancer treatment

We’re proud to announce that Health-Ecore is a key partner in the newly launched DELPHI project, a €1.8 million initiative aimed at transforming lung cancer care through personalized medicine. Coordinated by UMCG spin-off Protyon, the project brings together leading institutions including the University Medical Center Groningen (UMCG), the University of Groningen, Protyon, and Health-Ecore. Funding has been awarded by the Samenwerkingsverband Noord-Nederland (SNN) through the Just Transition Fund (JTF).

Driving Innovation in Oncology

The DELPHI project is focused on developing patient-specific treatment strategies for lung cancer using advanced molecular modelling and computational analysis. By creating detailed 3D models of cancer-driving proteins and analysing molecular fingerprints, the consortium aims to deliver highly personalized treatment recommendations that improve outcomes and reduce healthcare costs.

At Health-Ecore, we’re contributing our expertise in health-economics, showing the value of the transformative diagnostic tool to pursue highly personalized healthcare. This will include insight in the cost-effectiveness of the tool, as well as potential pricing strategies.

Addressing a Global Health Challenge

Lung cancer is the most commonly diagnosed cancer worldwide and the leading cause of cancer-related deaths, with approximately 2 million new cases and 1.8 million deaths each year. In the Netherlands alone, around 13,000 people are diagnosed annually. The DELPHI project addresses this urgent challenge by pushing the boundaries of personalized oncology.

A Strong Collaborative Foundation

The project builds on established collaborations between UMCG, the University of Groningen, and regional SMEs including Health-Ecore and Protyon. Protyon is pioneering the use of molecular modeling to tackle non-small cell lung cancer (NSCLC), supported by the UMCG Innovation Center and the Health~Holland TKI/PPP scheme.

The DELPHI project officially kicked off on December 4th, and the consortium is now moving forward with a shared vision: to bring innovative, personalized solutions to patients and create meaningful impact for society.

Meet the Team

• UMCG: Craig Grove, Anthonie van der Wekken, Anke van den Berg
• University of Groningen: Matthew Groves
• Health-Ecore BV: Simon van der Pol
• Protyon: Rositsa Jordanova

This project is co-funded by